The realisation that NF- kappaB activity is regulated by kinases and ubiquitin modifying enzymes presents multiple opportunities for therapeutic intervention. In addition to highlights from basic research, results from clinical trials using IKK and other NF- kappaB inhibitors are expected to be presented at this meeting.
Keystone Symposia: NF-kappaB in Inflammation and Disease
5 - 10 January 2010, Santa Fe, New Mexico, United States
Introduction
Venue
Eldorado Hotel & Spa
Eldorado Hotel & Spa, Santa Fe, New Mexico, United States
Organised by
Michelle A. Kelliher, Manolis Pasparakis and Jürg Tschopp
Contact information
Related events
What's in that Perfume? - The 91AV behind an iconic Christmas gift
3 December 2024 18:00-20:00, London, United Kingdom
Joint SoBRA / RSC Winter Conference 2024 Current Issues in Contaminated Land Risk Assessment
10 December 2024 09:45-18:00, London, United Kingdom
From bench to bedside - Advancements in prosthetic/artificial heart valve devices
25 February 2025 17:00-18:30
Royal Australian Chemical Institute 2nd Green and Sustainable 91AV and Engineering Conference
8 December 2024 17:00 - 12 December 2024 15:00, Melbourne, Australia
Search
Advertisement
Spotlight
Explore
Membership
